6533b82cfe1ef96bd129020f

RESEARCH PRODUCT

Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology.

Daniel SascaIgor TsaurAxel HaferkampRobert DotzauerStefan PorubskyThomas HöfnerHendrik Borgmann

subject

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)UrologyUrologic OncologyCOVID-19High-Throughput Nucleotide SequencingComputational biologyPrecision medicineMedical OncologyDNA sequencingPandemicMutationResearch LetterMedicineHumansPrecision Medicinebusiness
yearjournalcountryeditionlanguage
2021-02-01European urology
10.1016/j.eururo.2021.02.037https://pubmed.ncbi.nlm.nih.gov/33674179